Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy. [electronic resource]
Producer: 20060814Description: 3583-9 p. digitalISSN:- 1527-7755
- Adolescent
- Anemia, Hypochromic -- drug therapy
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bone Marrow -- drug effects
- Child
- Child, Preschool
- Double-Blind Method
- Epoetin Alfa
- Erythrocyte Transfusion
- Erythropoietin -- administration & dosage
- Female
- Health Status
- Hematinics -- administration & dosage
- Hemoglobins -- analysis
- Humans
- Male
- Neoplasms -- drug therapy
- Quality of Life
- Recombinant Proteins
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.